Cargando…
Elevated serum trimethylamine oxide levels as potential biomarker for diabetic kidney disease
BACKGROUND: Diabetic kidney disease (DKD) has become a major cause of chronic kidney disease. However, early diagnosis of DKD is challenging. Trimethylamine oxide (TMAO) is an intestinal microbial metabolite which might be associated with diabetes complications. The aim of this study was to investig...
Autores principales: | Huang, Yinqiong, Zhu, Zhaozhao, Huang, Zhiqin, Zhou, Jingxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388659/ https://www.ncbi.nlm.nih.gov/pubmed/37183928 http://dx.doi.org/10.1530/EC-22-0542 |
Ejemplares similares
-
Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy
por: Liu, Weiming, et al.
Publicado: (2020) -
Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke
por: Rexidamu, Maimaiti, et al.
Publicado: (2019) -
Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease
por: Bean, Lamuel D., et al.
Publicado: (2022) -
Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease
por: Fang, Qing, et al.
Publicado: (2021) -
Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate
por: Pelletier, Caroline C., et al.
Publicado: (2019)